Table 2.
Participant Characteristics (N = 160)
| Characteristic | Participants |
|---|---|
| Years since medical school, % | |
| 0 to 10 | 27 |
| 11 to 20 | 36 |
| 21 to 30 | 23 |
| 31 to 40 | 11 |
| > 40 | 3 |
| Female sex, % | 37 |
| Type of physician, % | |
| Surgical specialist | 29 |
| Medical oncologist | 57 |
| Radiation oncologist | 14 |
| Research principal investigator, %* | |
| Clinical trials | 50 |
| Translational science | 33 |
| Basic science | 21 |
| Outcomes | 21 |
| Other | 2 |
| Not principal investigator | 17 |
| No. of new patients each month | |
| Mean | 12.5 |
| SD | 10.0 |
| Percentage of patients recommended for phase one | |
| Mean | 16.9 |
| SD | 19.5 |
| Professional effort, % | |
| Patient care | |
| Mean | 50.0 |
| SD | 26.3 |
| Research | |
| Mean | 35.5 |
| SD | 27.4 |
| Teaching | |
| Mean | 11.8 |
| SD | 12.5 |
| Administration | |
| Mean | 12.8 |
| SD | 15.2 |
| Baseline genomic testing, % | |
| Mean | 24.3 |
| SD | 29.2 |
Abbreviation: SD, standard deviation.
*
Percentages do not add up to 100 because some participants are principal investigators in more than one area.